Its availability is limited to research markets, and using it in humans carries both legal and health risks
The FEP Medicare Prescription Drug Program is a prescription drug plan with a Medicare contract
Subsequent gastroparesis management, including regular physician visits, medications, nutritional counseling, and potential surgical interventions, can cost $20,000 to $50,000 annually
The company's CT-388 dual agonist and CT-996 oral formulation are progressing through Phase II trials, with potential market entry expected by 2029
This can cause irregular menstrual cycles or temporarily absent periods, disrupted ovulation timing where you might ovulate earlier or later than expected, changes in estrogen, progesterone, and other reproductive hormones, and temporary changes in cervical mucus quality